Skip to content
10-Q

Quarterly Report

HEMAGEN DIAGNOSTICS INC

0001445866-12-000060

← back to feed
Filed
Feb 14, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q1 2012 · Dec 31, 2011 15.49M sh
Shares Diluted Q1 2012 · Dec 31, 2010 15.47M sh
Shares Outstanding Q1 2012 · Dec 31, 2011 15.49M sh
Capex Q1 2012 · Dec 31, 2011 −$64.7K
Capex Q1 2012 · Dec 31, 2010 −$29.46K
Operating Cash Flow Q1 2012 · Dec 31, 2011 −$208.19K
Operating Cash Flow Q1 2012 · Dec 31, 2010 $64.71K
Cash And Equivalents Q1 2012 · Dec 31, 2011 $18.86K
Cash And Equivalents Q1 2012 · Sep 30, 2011 $213.61K
Cash And Equivalents Q1 2012 · Dec 31, 2010 $256.67K
Cash And Equivalents Q1 2012 · Sep 30, 2010 $151.74K
Stockholders Equity Q1 2012 · Dec 31, 2011 −$3.04M
Stockholders Equity Q1 2012 · Sep 30, 2011 −$2.69M
Current Liabilities Q1 2012 · Dec 31, 2011 $1.58M
Current Liabilities Q1 2012 · Sep 30, 2011 $1.53M
Total Liabilities Q1 2012 · Dec 31, 2011 $5.63M
Total Liabilities Q1 2012 · Sep 30, 2011 $5.58M
Current Assets Q1 2012 · Dec 31, 2011 $2.14M
Current Assets Q1 2012 · Sep 30, 2011 $2.45M
Total Assets Q1 2012 · Dec 31, 2011 $2.59M
Total Assets Q1 2012 · Sep 30, 2011 $2.89M
Eps Diluted Q1 2012 · Dec 31, 2011 −$0.02
Eps Diluted Q1 2012 · Dec 31, 2010 −$0.01
Eps Basic Q1 2012 · Dec 31, 2011 −$0.02
Eps Basic Q1 2012 · Dec 31, 2010 −$0.01
Sga Expense Q1 2012 · Dec 31, 2011 $661.3K
Sga Expense Q1 2012 · Dec 31, 2010 $599.89K
Rd Expense Q1 2012 · Dec 31, 2011 $740
Rd Expense Q1 2012 · Dec 31, 2010 $1.38K
Net Income Q1 2012 · Dec 31, 2011 −$368.56K
Net Income Q1 2012 · Dec 31, 2010 −$184.18K
Operating Income Q1 2012 · Dec 31, 2011 −$254.71K
Operating Income Q1 2012 · Dec 31, 2010 −$91.46K
Gross Profit Q1 2012 · Dec 31, 2011 $407.33K
Gross Profit Q1 2012 · Dec 31, 2010 $509.81K
Cost Of Revenue Q1 2012 · Dec 31, 2011 $699.74K
Cost Of Revenue Q1 2012 · Dec 31, 2010 $866.86K
Revenue Q1 2012 · Dec 31, 2011 $1.11M
Revenue Q1 2012 · Dec 31, 2010 $1.38M